The emerging treatment of the medication represents a major development in the care of type 2 diabetes. Distinct from existing medications, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide061117.targetblogs.com/42323483/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment